Guardant Health Inc
NASDAQ:GH 2:18:05 PM EDT
| Market Cap (Intraday) | 11.70B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $118.68 |
| 50-Day MA | $135.05 |
| 200-Day MA | $130.21 |
Guardant Health Inc Stock, NASDAQ:GH
505 Penobscot Drive, Redwood City, California 94063
United States of America
Phone: +1.855.698.8887
Number of Employees: 864
Description
Guardant Health, Inc. is a precision oncology company, which engages in treatment of cancer through use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2012 and is headquartered in Redwood City, CA.